Literature DB >> 25553166

Transurethral holmium laser vaporization to the urethral tumour through a ureteroscope.

Aihua Li1, Wei Fang1, Xiaoming Zuo1, Feng Zhang1, Weiwu Li1, Honghai Lu1, Sikuan Liu1, Hui Wang1, Binghui Zhang1.   

Abstract

We present 2 cases of urethral cancers: one is recurrent bladder transitional cell carcinoma accompanied by urethral metastatic carcinoma located on the right side of verumontanum, and the other is primary bladder and metastatic urethral adenocarcinoma. The urethral tumour was treated by transurethral holmium laser vaporization to the urethral tumour through a ureteroscope and the bladder tumour was treated with transurethral resection and degeneration of the bladder tumour (TURD-Bt). After the second or third therapy, patients were free of urethral or bladder tumour recurrence; they also did not experience urethral stricture or urinary incontinence during the 24- to 36-month follow-up. Transurethral holmium laser vaporization and TURD-Bt could be performed to treat non-invasive urethral cancer accompanied with bladder cancer and preserve the urethra and bladder.

Entities:  

Year:  2014        PMID: 25553166      PMCID: PMC4277533          DOI: 10.5489/cuaj.2026

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  9 in total

1.  The diagnosis and treatment of urethral recurrence after radical cystectomy.

Authors:  Jennifer B Sherwood; Arthur I Sagalowsky
Journal:  Urol Oncol       Date:  2006 Jul-Aug       Impact factor: 3.498

2.  Preservation of erectile function and urinary continence in squamous cell carcinoma of the bulbomembranous urethra.

Authors:  Mohammad Samzadeh; Abbas Basiri
Journal:  Urol J       Date:  2012       Impact factor: 1.510

Review 3.  Management of advanced primary urethral carcinomas.

Authors:  Farshid Dayyani; Karen Hoffman; Patricia Eifel; Charles Guo; Raghu Vikram; Lance C Pagliaro; Curtis Pettaway
Journal:  BJU Int       Date:  2014-05-22       Impact factor: 5.588

4.  [Diagnosis and treatment of urethral recurrence after radical cystectomy in the male].

Authors:  J Huguet
Journal:  Actas Urol Esp       Date:  2011-08-06       Impact factor: 0.994

Review 5.  EAU guidelines on primary urethral carcinoma.

Authors:  Georgios Gakis; J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Thierry Lebret; Maria J Ribal; Amir M Sherif
Journal:  Eur Urol       Date:  2013-04-02       Impact factor: 20.096

6.  The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer.

Authors:  Peter E Clark; John P Stein; Susan G Groshen; Gus Miranda; Jie Cai; Gary Lieskovsky; Donald G Skinner
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

7.  Transurethral resection and degeneration of bladder tumour.

Authors:  Aihua Li; Wei Fang; Feng Zhang; Weiwu Li; Honghai Lu; Sikuan Liu; Hui Wang; Binghui Zhang
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

Review 8.  Urethral cancer.

Authors:  Petros D Grivas; Matthew Davenport; James E Montie; L Priya Kunju; Felix Feng; Alon Z Weizer
Journal:  Hematol Oncol Clin North Am       Date:  2012-12       Impact factor: 3.722

9.  Holmium laser fulguration of superficial urothelial carcinoma of the pendulous urethra.

Authors:  Michael A Liss; Leland Ronningen; Atreya Dash
Journal:  Indian J Urol       Date:  2012-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.